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HTLV-1 infection leads to adult T-cell leukemia (ATL)
after long latent infection period. We have established
an HTLV-1-infected humanized NOG mouse model to
analyze the mechanism of ATL development. Huma-
nized mice were inoculated with Jurkat-based HTLV-1
producing cells, JEX, into peritoneal cavity to infect
human T-cells with HTLV-1. Infected T-cells prolifer-
ated vigorously in infected mice and the mice died of
ALT-like lymphoproliferative disorder with attenuated
HTLV-1 specific immunoresponses within two to three
months of infection. In contrast, when HTLV-1 produ-
cing cells were inoculated orally, infection of human
T-cells was established but the proviral loads (PVL) was
kept constant in small amount (0.2-9.5 copies / 100
PBMCs) without any pathological feature, even after 18
weeks post infection. The amount of antibody against
HTLV-1 in the plasma of orally infected mice was
equivalent to that of intraperitoneally infected mice at
2-6 weeks post infection. The titer of antibody was main-
tained throughout lifetime in orally infected mice but not
in intraperitoneally infected mice. Furthermore, depletion
of CD8 T-cells from orally infected mice by injecting
anti-CD8 antibody resulted in transient increase of PVL
in PBMCs, indicating the involvement of cytotoxic
T-cells in the control of PVL in these mice. Thus, orally
infected humanized NOG mice should provide a model
system of HTLV-1 carrier to examine factors involved in
the development of ATL from carrier state and play a sig-
nificant role in evaluating preventive vaccine candidates
and antiretroviral drugs for HTLV-1 infection.
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